Enhabit, Inc. · NYSE:EHAB
Enhabit — Jefferies Healthcare Services Conference 2025
16 slides from Enhabit's conference presentation, Sep 29, 2025
Slide 1: Jefferies Healthcare Services Conference Supplemental Information
Jefferies Healthcare Services Conference Supplemental Information September 30, 2025
Slide 2: Disclaimer: Forward looking statements
Enhabit Home Health & Hospice 2 Disclaimer Forward looking statements This presentation contains historical information, as well as forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amen
Slide 3: Overview
Enhabit Home Health & Hospice 3 Overview 108 Hospice locations co-located with Home Health locations(1) Home Health Locations Hospice Locations Home Health & Hospice State Home Health Only State (1) As of June 30, 2025 - due to scale, not all locations can be represented by locational markers 114 Ho
Slide 4: Large and Growing Addressable Markets
Enhabit Home Health & Hospice 4 (1) MedPAC Report to Congress as of March 2023. (2) MedPAC Tab H Hospice December 2024 (3) MedPAC Tab G Home Health December 2024. (Calculated based on 30-day home health period.) (4) AARP 2024 Survey. (5) Centers for Medicare & Medicaid Services, Medicare Trustees’ R
Slide 5: Advocacy: Response to the Proposed Medicare Cuts to Home Health
Advocacy: Response to the Proposed Medicare Cuts to Home Health Regulatory • Submitted comment letter in response to the CMS CY 2026 Home Health proposed rule. • The National Alliance for Care at Home (the Alliance), also submitted a comment letter - focused on the flawed methodology to calculate th
Slide 6: Access and Utilization Declining Nationally, but Not in California
Enhabit Home Health & Hospice | Confidential information 6 Access and Utilization Declining Nationally, but Not in California – Masking Decline National Excluding California 7,516 7,361 202420232022202120202019 8,518 8,127 7,914 7,686 -13.6% -4.6% -2.6% -2.9% -2.2% -2.1% Source: Dobson and Davanzo (
Slide 7: Without Home Health Access, Patient Outcomes Decline and Costs Increase
Enhabit Home Health & Hospice | Confidential information 7 Without Home Health Access, Patient Outcomes Decline and Costs Increase to Medicare Mortality Rate Increases by 41% Source: CMS Virtual Research Data Center Access to Home Health No Home Health 7.6% 10.7% +3.1 (+40.8%) Episodes with Readmiss
Slide 8: 2025 Priorities for Success
Enhabit Home Health & Hospice 8 2025 Priorities for Success • Home health momentum delivered 2nd quarter of sequential growth in net service revenue and Adjusted EBITDA, while continuing to stabilize Medicare ADC. • Hospice consistent growth with 6th straight quarter of sequential ADC growth; double
Slide 9: Balance Sheet Strength Continues to Improve
Enhabit Home Health & Hospice | Confidential information 9 Balance Sheet Strength Continues to Improve Q1 ’24 Q2 ’24 Q3 ’24 Q4 ’24 Q1 ’25 Q2 ’25 5.4 5.3 5.1 4.8 4.9 4.4 4.3 Q4 ’23 -1.1 (-20%) Leverage ratio decreased from Q4 2023 largely due to $75M in bank debt reduction during this period Leverage
Slide 10: Appendix
Enhabit Home Health & Hospice | Confidential information 10 Appendix
Slide 11: Q2 2025 Quarterly Results at a Glance
Enhabit Home Health & Hospice 11 Improved financial performance • Net income attributable to Enhabit, Inc. of $5.2 million. • Net service revenue grew 2.1% year over year and 2.4% sequentially to $266.1 million. • Adjusted EBITDA grew 6.7% year over year and 1.2% sequentially to $26.9 million. • Red
Slide 12: Debt & Liquidity Metrics
Enhabit Home Health & Hospice 12 Debt & Liquidity Metrics ($ in millions) June 30, 2025 December 31, 2024 $400 million term loan facility, due 2027(1)(2) $338.3 $348.0 Advances under revolving credit facility, due 2027(1) 135.0 160.0 Finance lease obligations 6.0 7.4 Total debt $479.3 $515.4 Less: C
Slide 13: Reconciliation of Net Income to Adjusted EBITDA
Enhabit Home Health & Hospice 13 Reconciliation of Net Income to Adjusted EBITDA ($ in millions) Q2 Year-To-Date 2025 2024 2025 2024 Net income $5.7 $0.4 $24.1 $1.3 Interest expense and amortization of debt discounts and fees 8.7 10.9 18.1 22.0 Provision for (benefit from) income taxes 2.3 (0.1) 9.7
Slide 14: Segment Adjusted EBITDA Reconciliation
Enhabit Home Health & Hospice | Confidential information 14 Q2 Year-To-Date ($ in millions) 2025 2024 2025 2024 Income before income taxes and noncontrolling interests $8.0 $0.3 $33.8 $2.1 Non-segment general and administrative expenses 27.8 32.9 55.5 63.4 Interest expense and amortization of debt d
Slide 15: Reconciliation of Net Income (Loss) to Trailing Twelve-Month Adjusted EBITDA
Enhabit Home Health & Hospice | Confidential information 15 Reconciliation of Net Income (Loss) to Trailing Twelve-Month Adjusted EBITDA ($ in millions) Quarter Ended Trailing Twelve Months Ended September 30, December 31, March 31, June 30, June 30, December 31, 2024 2024 2025 2025 2025 2024 Net in
Slide 16: Jefferies Healthcare Services Conference Supplemental Information
Jefferies Healthcare Services Conference Supplemental Information September 30, 2025
Enhabit — Jefferies Healthcare Services Conference 2025 on 6ix